These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35273002)

  • 1. Factors affecting voriconazole concentration to dose ratio changes according to route of administration.
    Chen C; Xu T; Zhou K; Zhu S
    Eur J Hosp Pharm; 2023 Dec; 31(1):31-35. PubMed ID: 35273002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of azole antifungal drugs on blood tacrolimus levels after switching from intravenous tacrolimus to once-daily modified release tacrolimus in patients receiving allogeneic hematopoietic stem cell transplantation.
    Mimura A; Yamaori S; Ikemura N; Katsuyama Y; Matsuzawa N; Ohmori S
    J Clin Pharm Ther; 2019 Aug; 44(4):565-571. PubMed ID: 30950099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus blood concentration increase depends on administration route when combined with voriconazole in pediatric stem cell transplant recipients.
    Utano T; Kato M; Osumi T; Shioda Y; Kiyotani C; Terashima K; Tomizawa D; Matsumoto K; Yamatani A
    Pediatr Transplant; 2020 Feb; 24(1):e13619. PubMed ID: 31820535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voriconazole concentration is inversely correlated with corticosteroid usage in immunocompromised patients.
    Imataki O; Yamaguchi K; Uemura M; Fukuoka N
    Transpl Infect Dis; 2018 Aug; 20(4):e12886. PubMed ID: 29570914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole trough concentration and hepatotoxicity in patients with low serum albumin
.
    Hirata A; Noto K; Ota R; Yokoyama S; Hosomi K; Takada M; Matsuoka H
    Int J Clin Pharmacol Ther; 2019 Mar; 57(3):135-143. PubMed ID: 30686290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic administration of voriconazole with two different doses for invasive fungal infection in children and adolescents with acute myeloid leukemia.
    Sano H; Kobayashi R; Hori D; Kishimoto K; Suzuki D; Yasuda K; Kobayashi K
    J Microbiol Immunol Infect; 2018 Apr; 51(2):260-266. PubMed ID: 27329132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between the CYP2C19 Phenotype Using the Voriconazole-to-Voriconazole N-Oxide Plasma Concentration Ratio and Demographic and Clinical Characteristics of Japanese Patients With Different CYP2C19 Genotypes.
    Niioka T; Fujishima N; Abumiya M; Yamashita T; Ubukawa K; Nara M; Fujishima M; Takahashi N; Miura M
    Ther Drug Monit; 2017 Oct; 39(5):514-521. PubMed ID: 28834922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive correlation between voriconazole trough concentrations and C-reactive protein levels in patients with chronic pulmonary aspergillosis: A retrospective cohort study.
    Miyakawa-Tanaka K; Suzuki J; Hirasawa Y; Nakamura S; Takeda K; Narumoto O; Matsui H
    J Infect Chemother; 2023 Jul; 29(7):683-687. PubMed ID: 36965708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Application Study of Voriconazole and Its Metabolites Concentration Monitoring in Allogeneic Hematopoietic Stem Cell Transplantation Patients].
    Wang HC; Wang L; Li M; Shi L; Sun HH; Liu HX; Ou HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):945-951. PubMed ID: 38926993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of Aspergillus empyema using combined intrathoracic and intravenous administration of voriconazole: A case report.
    Takatsuka H; Yamazaki S; Watanabe A; Yokoyama I; Suzuki T; Kamei K; Ishii I
    J Infect Chemother; 2020 Aug; 26(8):847-850. PubMed ID: 32414688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the Albumin-Bilirubin Score in Determining the Initial Dose of Voriconazole for Patients with Liver Cirrhosis.
    Nashimoto S; Imai S; Sugawara M; Takekuma Y
    Biol Pharm Bull; 2023; 46(2):230-236. PubMed ID: 36724951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective Study on the Usefulness of Initial Voriconazole Dose Adjustment Based on CYP2C19 Gene Polymorphism Analysis.
    Tanaka R; Fujioka T; Suzuki Y; Iwao M; Itoh H
    Chemotherapy; 2020; 65(3-4):59-64. PubMed ID: 32877905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical implication of therapeutic drug monitoring on voriconazole from the aspect of the analysis for CYP2C19 gene].
    Kimura M; Yamagishi Y; Kawasumi N; Hagihara M; Hasegawa T; Mikamo H
    Jpn J Antibiot; 2010 Jun; 63(3):255-64. PubMed ID: 20976881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of polymorphisms of pharmacokinetics-related genes and the inflammatory response on the metabolism of voriconazole.
    Aiuchi N; Nakagawa J; Sakuraba H; Takahata T; Kamata K; Saito N; Ueno K; Ishiyama M; Yamagata K; Kayaba H; Niioka T
    Pharmacol Res Perspect; 2022 Apr; 10(2):e00935. PubMed ID: 35199485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of voriconazole trough levels during therapy with enteral nutrition: a case report.
    Kaneko H; Yamazaki S; Uchida M; Suzuki T; Murakami K; Matsubara H; Kamei K; Ishii I
    J Pharm Health Care Sci; 2022 Feb; 8(1):6. PubMed ID: 35109934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of voriconazole oral dosage in Japan].
    Hamada Y; Kawasumi N; Hirai J; Yamagishi Y; Mikamo H
    Jpn J Antibiot; 2014 Oct; 67(5):279-84. PubMed ID: 25566590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of monitoring plasma concentration of voriconazole in a patient with liver failure: A case report.
    Liu X; Su H; Tong J; Chen J; Yang H; Xiao L; Hu J; Zhang L
    Medicine (Baltimore); 2017 Oct; 96(42):e8039. PubMed ID: 29049191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population Pharmacokinetics of Voriconazole in Patients With Invasive Aspergillosis: Serum Albumin Level as a Novel Marker for Clearance and Dosage Optimization.
    Chantharit P; Tantasawat M; Kasai H; Tanigawara Y
    Ther Drug Monit; 2020 Dec; 42(6):872-879. PubMed ID: 32947557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Implementation of Loading Dose of Voriconazole from 2010 to 2019 and Influencing Factors of Loading Dose Based on a Japanese Administrative Claim Database: A Retrospective Cohort Study.
    Inose R; Goto R; Shimoki M; Ohmagari N; Muraki Y
    Biol Pharm Bull; 2023; 46(12):1838-1841. PubMed ID: 38044104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Drug Monitoring of Oral Voriconazole in an Infant Less than Six Months of Age and Pharmacokinetics Changes Induced by Development of CYP2C19 in the Growth Process: A Novel Case Report.
    Yamaguchi A; Tazawa Y; Ueki M; Yamada M; Manabe A; Sugawara M; Takekuma Y
    Yakugaku Zasshi; 2023; 143(6):545-549. PubMed ID: 37258188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.